Those who are socially engaged and well-connected can lower their risk of dementia. Researchers from Australia understand the general concept of social engagement as a health-promoting activity „that should be encouraged in our society.“ For many years, researchers focused on developing new drugs and therapies that would slow the progression...
Loneliness and social isolation are risk factors for the development of dementia. This has been shown by international scientists in three studies. For example, loneliness can lead to an almost 60 percent increased risk of dementia. Some people enjoy being by themselves from time to time. But if loneliness is not consciously chosen...
If memory declines in older adults, it can significantly impair their daily lives and quality of life. Researchers from China have therefore addressed an important question regarding this issue: To what extent is computer-based cognitive training (CCT) effective in older adults with mild cognitive impairment (MCI) and...
The new Alzheimer's drug Lecanemab is raising great hopes for people with dementia and their caregivers. But which patient groups and how many affected individuals in Germany meet the criteria for treatment with Lecanemab? This essential question is a significant reason for us to dedicate another issue of our special newsletter to...
Scientists from Canada and the US demonstrated how the physical well-being of people with dementia and people with mild cognitive impairment (MCI) can be improved with the help of technology. Among other things, they identified the various types of interventions from technology-based group exercises for people with dementia or MCI and…
Most people know Dr. Sarah Straub (38) from numerous performances as a musician throughout Germany. However, she is also a specialist in frontotemporal dementia and a clinical neuropsychologist at Ulm University Hospital. There, she researches people with dementia and their caregivers. As an artist and as a dementia expert, she sees herself as...
The new Alzheimer's drug Lecanemab is raising great hopes for people with dementia and their caregivers. Very recently, a panel of experts from the European Medicines Agency (EMA) recommended the new active ingredient for treatment – subject to strict conditions. But which patient groups meet the requirements for treatment with Lecanemab? This...
In recent weeks, we have informed you in several parts of our special newsletter SCHLAGLICHT – Medications for Dementia about new dementia drugs and challenges in everyday care. You can reread all published issues at any time in our digiDEM Bavaria newsletter archive: https://digidem-bayern.de/newsletter-archiv/. In the seventh and final issue of our special newsletter SCHLAGLICHT – Medications for Dementia, Michael...
Which factors are associated with falls in people with dementia? Researchers from China investigated this. Their findings provide clear indications of which characteristics to focus on in fall prevention for people with cognitive impairments. While there are numerous studies that examine the risk factors for falls in older individuals...
People with Alzheimer's dementia fall more often than their cognitively healthy peers. Researchers from the USA have now substantiated this finding with a large review. In it, they summarized data on the frequency and number of falls, the reoccurrence rate of falls, and the number of falls that caused injuries. Older people who injured themselves...
